Small cap₹2,563 cr₹0.6 cr traded a dayThin: a ₹2 lakh order is 3.2% of a normal day
Close on 11 September 2026
5,306.50
+0.01%
52-week range65% of the way up
4,474.555,758.80
Market cap
2,563 cr
P/E (TTM)
33.6×
EPS (TTM)
157.81
Revenue YoY
+22.3%
Q1 FY27
Profit YoY
+35.5%
Net margin
16.4%
+1.6pt vs a year ago
Growth trend
+2.1pt
vs last quarter’s YoY
1 month
-2.1%
Below 52w high
7.9%
RSI (14)
46
Daily swing
2.6%
average true range
Volume
0.8×
vs 20-day average
Traded
₹1 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
Key metrics
each ranked against every stock scanned tonight
Above the 200-day average
Around the median
+5.3%
One-year return
Above the median
+16.8%
Return on capital employed
n/a
Debt to equity
n/a
Profitable quarters, last four
of the last four reported
4 of 4
Cash conversion
cash from operations against reported profit
n/a
Revenue growth, year on year
latest reported quarter
+22.3%
Below the 52-week high
distance from the highest close of the year
7.9%
How it has performed
price return over each window, beside the median NSE stock over the same days
The read
written from the numbers on this page
More of the measured facts point up than down5 supporting, 0 against, 1 worth knowing
Supporting
trading 5% above its 200-day average
up 17% over twelve months
matches profit jumped this quarter, which has beaten the market by +0.65 points over 20 sessions across 84,077 past signals
3 of the scans it matches have a positive measured record
revenue grew 22% year on year in the quarter ending 30 June 2026
Against
nothing the data supports either way
Worth knowing
the 5 scans it matches come from only 2 families — one signal wearing several hats rather than several signals
The market itself is rangebound tonight. Each scan's record is measured separately for this regime; the figure beside each chip above is the one that applies, not the all-weather number.
What would change these counts: the close crossing its 200-day average, which is 5,041 tonight and moves every session.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working5
Dr. Agrawals Eye Hospital's net profit rose 35.5% year on year, from Rs 17 cr to Rs 23 cr.
+35.5%Rs 17 crRs 23 cr
Dr. Agrawals Eye Hospital revenue rose 22.3% year on year, from Rs 117 cr to Rs 143 cr.
+22.3%Rs 117 crRs 143 cr
Dr. Agrawals Eye Hospital's net profit as a share of revenue moved from 14.8% to 16.4% against the same quarter last year.
14.8%16.4%
Trading 5.3% above its 200-day simple average, which is the line most investors use to separate a bull phase from a bear one.
+5.3%
Up 16.8% over the past year.
+16.8%
Needs watching1
Only ₹0.6 crore changes hands on a median day. A large order moves this price by itself.
₹0.6 cr
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 3 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
What the scans say today
5 of 57 matched on 11 Sep
DRAGARWQ matches 5 of the 57 scans today, across 2 different kinds of evidence (not counting 2 that match most of the market tonight). Note how few kinds of evidence that is: several scans in one family are one signal wearing several hats, not several signals. It is in none of the 19 published portfolios on the arena tonight.
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 22% against the same quarter a year earlier
profit rose 35% year on year
net margin widened from 13.5% to 16.4%
revenue rose in 3 of the last 4 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · standalone
143
31
23
48.38
16.4%
Q4 FY26
31 Mar · standalone
120
21
16
33.60
13.5%
Q3 FY26
31 Dec · standalone
116
23
17
35.76
14.9%
Q2 FY26
30 Sep · standalone
118
26
19
41.04
16.4%
Q1 FY26
30 Jun · standalone
117
23
17
36.72
14.8%
Q4 FY25
31 Mar · standalone
100
19
16
34.02
16.0%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Valuation against its own history
154 sessions since 3 February 2026
32×
median 34×
35×
now 34×
DRAGARWQ trades at 34× trailing earnings, close to its median of 34× over this window. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
How it is priced against the universe
tonight’s multiples, ranked against every company we scan
Measure
Tonight
Where it ranks
Price to earnings
trailing four quarters of profit
33.6×
cheaper than 41% of scanned companies
Price to sales
trailing four quarters of revenue
5.16×
cheaper than 25% of scanned companies
Earnings yield
3.0%
profit as a share of the market value — the P/E upside down
P/E to growth
0.95
the multiple divided by the year-on-year profit growth rate
Value composite
67
average percentile across the three multiples; 0 is the cheapest company scanned, 100 the dearest
Quality checklist
five of Piotroski’s nine tests, the ones Indian filings support
3 of 5
✓ profitable over four quarters✗ cash conversion above 100%✗ borrowings under half of equity✓ margin up on a year ago✓ revenue up on a year ago
A low multiple is a statement about expectations, not about quality: the market usually expects less from a cheap company, and is often right. These are rankings, not fair values.
Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423) · Dividend filings were typically +0.16pt vs the market over the next 5 sessions (n=940)
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+2.5%
Versus 200-day average+5.3%
Below 52-week high7.9%
Above 52-week low+18.6%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)46.1
Higher closes in last 52 of 5
Six-month return+11.71%
Risk and liquidity
What a position costs to hold and to exit. Delivery is the share of the day’s volume taken into demat rather than squared off; trade size says whether the day’s tickets were large or small.
Typical daily swing (ATR)2.63%
What ₹1 lakh here moves on a normal dayabout ₹2,629